New app aims to ease daily struggles for kidney dialysis patients

NCT ID NCT07211100

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a mobile app designed for people on hemodialysis. The app helps with medication, diet, fluid limits, and symptom tracking. 72 adults will be split into two groups: one uses the app, the other gets standard care. Researchers will check if the app improves treatment adherence and reduces symptoms like fatigue and itching over two months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
mobile health application
What this could lead to
If it works, this app could help hemodialysis patients better manage their diet, fluids, and symptoms, improving daily life and treatment adherence.
What could go wrong
This is a small, early-stage study with only 72 people over 2 months. The app may not show clear benefits, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE REQUIRING HAEMODIALYSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Gumushane State Hospital

    Gümüşhane, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.